{"doc_id": "32699167", "type of study": "Therapy", "title": "", "abstract": "Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor: protocol for a randomised controlled trial.\nThere is an outbreak of COVID-19 worldwide.\nAs there is no effective therapy or vaccine yet, rigorous implementation of traditional public health measures such as isolation and quarantine remains the most effective tool to control the outbreak.\nWhen an asymptomatic individual with COVID-19 exposure is being quarantined, it is necessary to perform temperature and symptom surveillance.\nAs such surveillance is intermittent in nature and highly dependent on self-discipline, it has limited effectiveness.\nAdvances in biosensor technologies made it possible to continuously monitor physiological parameters using wearable biosensors with a variety of form factors.\nTo explore the potential of using wearable biosensors to continuously monitor multidimensional physiological parameters for early detection of COVID-19 clinical progression.\nThis randomised controlled open-labelled trial will involve 200-1000 asymptomatic subjects with close COVID-19 contact under mandatory quarantine at designated facilities in Hong Kong.\nSubjects will be randomised to receive a remote monitoring strategy (intervention group) or standard strategy (control group) in a 1:1 ratio during the 14 day-quarantine period.\nIn addition to fever and symptom surveillance in the control group, subjects in the intervention group will wear wearable biosensors on their arms to continuously monitor skin temperature, respiratory rate, blood pressure, pulse rate, blood oxygen saturation and daily activities.\nThese physiological parameters will be transferred in real time to a smartphone application called Biovitals Sentinel.\nThese data will then be processed using a cloud-based multivariate physiology analytics engine called Biovitals to detect subtle physiological changes.\nThe results will be displayed on a web-based dashboard for clinicians' review.\nThe primary outcome is the time to diagnosis of COVID-19.\nETHICS AND DISSEMINATION : Ethical approval has been obtained from institutional review boards at the study sites.\nResults will be published in peer-reviewed journals.\n\u00a9 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC.\nNo commercial re-use. See rights and permissions.\nPublished by BMJ.\n", "Evidence Map": {"Enrollment": [{"term": "quarantine", "negation": "affirmed", "UMLS": {}, "start": 82, "end": 92}, {"term": "clinical progression", "negation": "affirmed", "UMLS": {}, "start": 152, "end": 172}, {"term": "asymptomatic", "negation": "affirmed", "UMLS": {}, "start": 69, "end": 81}, {"term": "close COVID-19 contact", "negation": "affirmed", "UMLS": {}, "start": 96, "end": 118}, {"term": "clinicians", "negation": "affirmed", "UMLS": {}, "start": 59, "end": 69}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor : protocol for a randomised controlled trial .", "Evidence Elements": {"Participant": [{"term": "quarantine", "negation": "affirmed", "UMLS": {}, "start": 82, "end": 92}], "Intervention": [{"term": "Artificial intelligence mobile health platform", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 46, "has_relation": "N/A"}, {"term": "biosensor", "negation": "affirmed", "UMLS": {}, "start": 119, "end": 128, "has_device": [{"text": "biosensor", "maps_to": "C0600364:biosensor", "start": 0, "end": 9}], "has_relation": "N/A"}], "Outcome": [{"term": "early detection of COVID-19", "negation": "affirmed", "UMLS": {}, "start": 51, "end": 78}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "There is an outbreak of COVID-19 worldwide .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "As there is no effective therapy or vaccine yet , rigorous implementation of traditional public health measures such as isolation and quarantine remains the most effective tool to control the outbreak .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "When an asymptomatic individual with COVID-19 exposure is being quarantined , it is necessary to perform temperature and symptom surveillance .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "As such surveillance is intermittent in nature and highly dependent on self-discipline , it has limited effectiveness .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "Advances in biosensor technologies made it possible to continuously monitor physiological parameters using wearable biosensors with a variety of form factors .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "OBJECTIVE", "Text": "To explore the potential of using wearable biosensors to continuously monitor multidimensional physiological parameters for early detection of COVID-19 clinical progression .", "Evidence Elements": {"Participant": [{"term": "clinical progression", "negation": "affirmed", "UMLS": {}, "start": 152, "end": 172}], "Intervention": [{"term": "wearable biosensors", "negation": "affirmed", "UMLS": {}, "start": 34, "end": 53, "has_device": [{"text": "wearable biosensors", "maps_to": "C0600364:biosensors", "start": 0, "end": 19}], "has_relation": "N/A"}], "Outcome": [{"term": "multidimensional physiological parameters", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 119}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHOD", "Text": "This randomised controlled open-labelled trial will involve 200-1000 asymptomatic subjects with close COVID-19 contact under mandatory quarantine at designated facilities in Hong Kong .", "Evidence Elements": {"Participant": [{"term": "asymptomatic", "negation": "affirmed", "UMLS": {}, "start": 69, "end": 81}, {"term": "close COVID-19 contact", "negation": "affirmed", "UMLS": {}, "start": 96, "end": 118}], "Intervention": [{"term": "quarantine", "negation": "affirmed", "UMLS": {}, "start": 135, "end": 145, "has_procedure": [{"text": "quarantine", "maps_to": "C0034386:quarantine", "start": 0, "end": 10}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHOD", "Text": "Subjects will be randomised to receive a remote monitoring strategy ( intervention group ) or standard strategy ( control group ) in a 1:1 ratio during the 14 day-quarantine period .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "remote monitoring strategy", "negation": "affirmed", "UMLS": {}, "start": 41, "end": 67, "has_relation": "N/A"}, {"term": "standard strategy", "negation": "affirmed", "UMLS": {}, "start": 94, "end": 111, "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHOD", "Text": "In addition to fever and symptom surveillance in the control group , subjects in the intervention group will wear wearable biosensors on their arms to continuously monitor skin temperature , respiratory rate , blood pressure , pulse rate , blood oxygen saturation and daily activities .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "intervention", "negation": "affirmed", "UMLS": {}, "start": 85, "end": 97, "has_procedure": [{"text": "intervention", "maps_to": "C0886296:intervention", "start": 0, "end": 12}], "has_relation": "N/A"}], "Outcome": [{"term": "fever", "negation": "affirmed", "UMLS": {}, "start": 15, "end": 20}, {"term": "symptom surveillance", "negation": "affirmed", "UMLS": {}, "start": 25, "end": 45}, {"term": "skin temperature", "negation": "affirmed", "UMLS": {}, "start": 172, "end": 188}, {"term": "respiratory rate", "negation": "affirmed", "UMLS": {}, "start": 191, "end": 207}, {"term": "blood pressure", "negation": "affirmed", "UMLS": {}, "start": 210, "end": 224}, {"term": "pulse rate", "negation": "affirmed", "UMLS": {}, "start": 227, "end": 237}, {"term": "blood", "negation": "affirmed", "UMLS": {}, "start": 210, "end": 215}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHOD", "Text": "These physiological parameters will be transferred in real time to a smartphone application called Biovitals Sentinel .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHOD", "Text": "These data will then be processed using a cloud-based multivariate physiology analytics engine called Biovitals to detect subtle physiological changes .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHOD", "Text": "The results will be displayed on a web-based dashboard for clinicians ' review .", "Evidence Elements": {"Participant": [{"term": "clinicians", "negation": "affirmed", "UMLS": {}, "start": 59, "end": 69}], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHOD", "Text": "The primary outcome is the time to diagnosis of COVID-19 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "time to diagnosis of COVID-19", "negation": "affirmed", "UMLS": {}, "start": 27, "end": 56}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "ETHICS AND DISSEMINATION : Ethical approval has been obtained from institutional review boards at the study sites .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Results will be published in peer-reviewed journals .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "\u00a9 Author (s ) ( or their employer (s ) ) 2020 . Re-use permitted under CC BY-NC .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "No commercial re-use . See rights and permissions .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Published by BMJ .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}